-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Microbot Medical, Lowers Price Target to $2

Benzinga·11/17/2026 14:15:30
Listen to the news
Citizens analyst Daniel Stauder maintains Microbot Medical (NASDAQ:MBOT) with a Market Outperform and lowers the price target from $2.5 to $2.